(7R)-Eras-4001, CAS [[3024878-21-2]] Preis auf Anfrage

Artikelnummer: MCE-HY-175870A
Artikelname: (7R)-Eras-4001, CAS [[3024878-21-2]] Preis auf Anfrage
Artikelnummer: MCE-HY-175870A
Hersteller Artikelnummer: HY-175870A
Alternativnummer: MCE-HY-175870A-1UNIT
Hersteller: MedchemExpress
Kategorie: Biochemikalien
(7R)-Eras-4001 is an orally active KRAS mutant inhibitor with remarkable selectivity for H-RAS and N-RAS. (7R)-Eras-4001 effectively suppresses cancer cell viability by blocking downstream signaling pathways mediated by RAF family proteins, inhibiting the formation of the KRASG12D-RAF1 RBD complex and the phosphorylation of ERK1/2. (7R)-Eras-4001 induces tumor growth inhibition and regression in a dose-dependent manner, and also reduces plasma ERK1/2 phosphorylation levels. (7R)-Eras-4001 exerts a synergistic effect with anti-PD-1 Cetuximab (HY-P9905). (7R)-Eras-4001 can be used in research on non-small cell lung cancer, pancreatic cancer, colorectal cancer, and ovarian cancer[1][2].
Molekulargewicht: 743.19
CAS Nummer: [3024878-21-2]
Formel: C36H39ClF4N8O3
Target-Kategorie: ERK,Ras
Anwendungsbeschreibung: MCE Product type: Reference compound